Advertisement

Both high and low HCG day progesterone concentrations negatively affect live birth rates in IVF/ICSI cycles

      Abstract

      Research question

      Can previous reports of a decreased probability of success in stimulated IVF cycles with premature rise of progesterone, as determined by progesterone concentration on HCG day (PHCG), be confirmed?

      Design

      Retrospective, observational, single-centre cohort study conducted on 5447 IVF and intracytoplasmic (ICSI) cycles carried out among 2192 patients between 2009 and 2015, with conventional ovarian stimulation. This large database was used to develop a non-linear mixed prognosis model of live birth rate (LBR) incorporating PHCG as a predictor.

      Results

      In addition to known predictors (age, body mass index, anti-Müllerian hormone, type of infertility), PHCG was associated with a linear effect (OR 0.78 per Log[PHCG]ng/ml, 95% CI 0.611 to 0.997, P = 0.047) combined with a strong quadratic effect (OR 0.585 per Log2(PHCG)ng/ml, 95% CI 0.444 to 0.775, P < 0.001) resulting into a parabolic reverse-U curve. A significant interaction (P = 0.038) was found between PHCG and number of oocytes if three or less, but the effect of PHCG remains modest. For higher oocyte numbers, LBR rapidly increases with number of retrieved oocytes; however, LBR becomes more sensitive to PHCG as the number of oocytes increases. Higher live birth prognoses occur for optimal PHCG but are sharply reduced for lower or higher PHCG.

      Conclusions

      Evidence is provided of an important negative effect of PHCG at lower and higher values, independent of oocyte number, thus defining appropriate ranges for fresh embryo transfer or freeze-all strategy. In poor responders, premature progesterone rise may be ignored, thus avoiding unnecessary cancellations or embryo freezing. Conversely, in higher responders, the negative effect of progesterone elevation is more pronounced, suggesting that freeze-all policy should be applied more widely.

      KEYWORDS

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Reproductive BioMedicine Online
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Acharya K.S.
        • Acharya C.R.
        • Bishop K.
        • Harris B.
        • Raburn D.
        • Muasher S.J.
        Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry.
        Fertil. Steril. 2018 Oct; 110: 880-887
        • Aflatoonian A.
        • Davar R.
        • Hojjat F.
        Elevated serum progesterone/ MII oocyte ratio on the day of human chorionic gonadotropin administration can predict impaired endometrial receptivity.
        Iran. J. Reprod. Med. 2014 Jun; 12: 427-434
        • Arvis P.
        • Lehert P.
        • Guivarc'h-Levêque A.
        Simple adaptations to the Templeton model for IVF outcome prediction make it current and clinically useful.
        Hum. Reprod. 2012 Oct; 27: 2971-2978
        • Berin I.
        • Skorupski J.C.
        • Stein D.E.
        • Keltz M.D.
        Elevated serum progesterone/estradiol ratio and progesterone level during in vitro fertilization are negative predictors of cycle outcome.
        Fertil. Steril. 2006; 86: S169
        • Bosch E.
        • Valencia I.
        • Escudero E.
        • Crespo J.
        • Simon C.
        • Remohi J.
        • Pellicer A.
        Premature luteinization during gonadotropin releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome.
        Fertil. Steril. 2003; 80: 1444-1449
        • Bosch E.
        • Labarta E.
        • Crespo J.
        • Simon C.
        • Remohi J.
        • Jenkins J.
        • Pellicer A.
        Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles.
        Hum. Reprod. 2010; 25: 2092-2100
        • Bourgain C.
        • Ubaldi F.
        • Tavaniotou A.
        • Smitz J.M.
        • Van Steirteghem A.C.
        • Devroey P.
        Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome.
        Fertil. Steril. 2002; 78: 237-244
        • Cohen-Bacrie P.
        • Cohen-Bacrie M.
        • Hazout A.
        • Lichtblau I.
        • Dumont M.
        • Junca A.M.
        • Belloc S.
        • Prisant N.
        • de Mouzon J.
        Serum progesterone/estradiol ratio on the day of HCG is more predictive for ART cycle outcome than progesterone itself.
        Hum. Reprod. 2012; 27: 226-247
        • Devroey P.
        • Pellicer A.
        • Nyboe Andersen A.
        • Arce J.C.
        • Menopur in GnRH Antagonist Cycles with Single Embryo Transfer Trial Group
        A randomized assessor-blind trial comparing highly purified hMGand recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer.
        Fertil. Steril. 2012; 97: 561-571
        • Edelstein M.C.
        • Seltman H.J.
        • Cox B.J.
        • Robinson S.M.
        • Shaw R.A.
        • Muasher S.J.
        Progesterone levels on the day of human chorionic gonadotropin administration in cycles with gonadotropin-releasing hormone agonist suppression are not predictive of pregnancy outcome.
        Fertil. Steril. 1990; 54: 853-857
        • Elgindy E.A.
        Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy.
        Fertil. Steril. 2011; 95: 1639-1644
        • Erdem M.
        • Mutlu M.F.
        • Erdem A.
        • Mutlu I.
        • Guler I.
        • Oktem M.
        The predictive value of early follicular progesteron on preovulatuary progesterone rise in IVF cycles with GNRH antagonist protocol.
        Fertil. Steril. 2015; 104 (S,e324): 324
        • Griesinger G.
        • Mannaerts B.
        • Yding Andersen C.
        • Witjes H.
        • Kolibianakis E.M.
        • Gordon K.
        Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of invitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials.
        Fertil. Steril. 2013; 100: 1622-1628
        • Grin L.
        • Mizrachi Y.
        • Cohen O.
        • Lazer T.
        • Liberty G.
        • Meltcer S.
        • Friedler S.
        Does progesterone to oocyte index have a predictive value for IVF outcome? A retrospective cohort and review of the literature.
        Gynecol. Endocrinol. 2018; 26: 1-6
        • Hamdine O.
        • Macklon N.S.
        • Eijkemans M.J.
        • Laven J.S.
        • Cohlen B.J.
        • Verhoeff A.
        • van Dop P.A.
        • Bernardus R.E.
        • Lambalk C.B.
        • Oosterhuis G.J.
        • Holleboom C.A.
        • van den Dool-Maasland G.C.
        • Verburg H.J.
        • van der Heijden P.F.
        • Blankhart A.
        • Fauser B.C.
        Broekmans FJ 6 Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis.
        Fertil. Steril. 2014; 102: 448-454
        • Healy M.W.
        • Patounakis G.
        • Connell M.T.
        • Devine K.
        • DeCherney A.H.
        • Levy M.J.
        • Hill M.J.
        Does a frozen embryo transfer ameliorate the effect of elevated progesterone seen in fresh transfer cycles?.
        Fertil. Steril. 2016; 105: 93-99
        • Hill M.J.
        • Healy M.W.
        • Richter K.S.
        • Widra E.
        • Levens E.D.
        • DeCherney A.H.
        • Patounakis G.
        • Whitcomb B.W.
        Revisiting the progesterone to oocyte ratio.
        Fertil. Steril. 2017; 107: 671-676
        • Hugues J.N.
        • Masse-Laroche E.
        • Reboul-Marty J.
        • Boiko O.
        • Meynant C.
        • Cedrin-Durnerin I.
        Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.
        Fertil. Steril. 2011; 96: 600-604
        • Keltz M.D.
        • Stein D.E.
        • Berin I.
        • Skorupski J.
        Elevated progesterone-to-estradiol ratio versus serum progesterone alone for predicting poor cycle outcome with in vitro fertilization.
        J. Reprod. Med. 2012 Jan-Feb; 57: 9-12
        • Kolibianakis E.M.
        • Zikopoulos K.
        • Smitz J.
        • Camus M.
        • Tournaye H.
        • Van Steirteghem A.C.
        • Devroey P.
        Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists.
        Hum. Reprod. 2004; 19: 1525-1529
        • Kyrou D.
        • Kolibianakis E.M.
        • Fatemi H.M.
        • Camus M.
        • Tournaye H.
        • Tarlatzis B.C.
        • Devroey P.
        High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection.
        Fertil. Steril. 2011; 96: 884-888
        • Kyrou D.
        • Al-Azemi M.
        • Papanikolaou E.G.
        • Donoso P.
        • Tziomalos K.
        • Devroey P.
        • Fatemi H.M.
        The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles.
        Eur. J. Obstet. Gynecol. Reprod. Biol. 2012; 162: 165-168
        • Labarta E.
        • Martinez-Conejero J.A.
        • Alama P.
        • Horcajadas J.A.
        • Pellicer A.
        • Simon C.
        • Bosch E.
        Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis.
        Hum. Reprod. 2011; 26: 1813-1825
        • Lin Y.J.
        • Lan K.C.
        • Huang F.J.
        • Lin P.Y.
        • Chiang H.J.
        • Kung F.T.
        Reproducibility and clinical significance of pre-ovulatory serum progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in infertile women undergoing repeated in vitro fertilization cycles.
        Reprod. Biol. Endocrinol. 2015 May 13; 13: 41
        • Papanikolaou E.G.
        • Pados G.
        • Grimbizis G.
        • Bili E.
        • Kyriazi L.
        • Polyzos N.P.
        • Humaidan P.
        • Toumaye H.
        • Tariatzis B.
        GnRH-agonist versus GnRH-antagonist IVF cycles: Is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.
        Hum. Reprod. 2012; 27: 1822-1828
        • Pencina M.J.
        • D'Agostino Sr, R.B.
        • D'Agostino Jr, R.B.
        • Vasan R.S.
        Evaluating the added predictive ability of a new marker: from area under the ROC curve toreclassification and beyond.
        Stat. Med. 2008 Jan 30; 27: 157-172
        • Pettersson G.
        • Andersen A.N.
        • Broberg P.
        • Arce J.C.
        Pre-stimulation parameters predicting live birth after IVF in the long GnRH agonist protocol.
        Reprod. Biomed. Online. 2010 May; 20: 572-581
        • Nelson S.M.
        • Lawlor D.A.
        Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles.
        PLoS. Med. 2011 Jan 4; 8e1000386
        • Papaleo E.
        • Corti L.
        • Vanni V.S.
        • Pagliardini L.
        • Ottolina J.
        • De Michele F.
        • La Marca A.
        • Viganò P.
        • Candiani M.
        Basal progesterone level as the main determinant of progesterone elevation on the day of hCG triggering in controlled ovarian stimulation cycles.
        Arch. Gynecol. Obstet. 2014 Jul; 290: 169-176
        • Park J.H.
        • Jee B.C.
        • Kim S.H.
        Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles.
        Clin. Exp. Reprod. Med. 2015; 42: 67-71
        • Patton P.E.
        • Lim J.Y.
        • Hickok L.R.
        • Kettel L.M.
        • Larson J.M.
        • Pau K.Y.
        Precision of progesterone measurements with the use of automated immunoassay analyzers and the impact on clinical decisions for in vitro fertilization.
        Fertil. Steril. 2014; 101: 1629-1636
        • Racca A.
        • Santos-Ribeiro S.
        • De Munck N.
        • Mackens S.
        • Drakopoulos P.
        • Camus M.
        • Verheyen G.
        • Tournaye H.
        • Blockeel C.
        Impact of late-follicular phase elevated serum progesterone on cumulative live birth rates: is there a deleterious effect on embryo quality?.
        Hum. Reprod. 2018; 33: 1-9
        • Requena A.
        • Cruz M.
        • Bosch E.
        • Meseguer M.
        • Garcia-Velasco J.A.
        High progesterone levels in women with high ovarian response do not affect clinical outcomes: a retrospective cohort study.
        Reprod. Biol. Endocrinol. 2014; 12: 69
        • Santos-Ribeiro S.
        • Polyzos N.P.
        • Haentjens P.
        • Smitz J.
        • Camus M.
        • Tournaye H.
        • Blockeel C.
        Live birth rates after IVF are reduced by both low and high progesterone levels on the day of human chorionic gonadotrophin administration.
        Hum. Reprod. 2014 Aug; 29: 1698-1705
        • Schneyer A.L.
        • Fujiwara T.
        • Fox J.
        • Welt C.K.
        • Adams J.
        • Messerlian G.M.
        • Taylor A.E.
        Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations.
        J. Clin. Endocrinol. Metab. 2000; 85: 3319-3330
        • Seow K.M.
        • Lin Y.H.
        • Hsieh B.C.
        • Huang L.W.
        • Huang S.C.
        • Chen C.Y.
        • Chen P.H.
        • Tzeng C.R.
        • Hwang J.L.
        Characteristics of progesterone changes in women with subtle progesterone rise in recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonist cycle.
        Gynecol. Obstet. Invest. 2010; 70: 64-68
        • Shapiro B.S.
        • Daneshmand S.T.
        • Garner F.C.
        • Aguirre M.
        • Hudson C.
        • Thomas S.
        Embryo cryopreservation rescues cycles with premature luteinisation.
        Fertil. Steril. 2010; 93: 636-641
        • Shufaro Y.
        • Sapir O.
        • Oron G.
        • Ben Haroush A.
        • Garor R.
        • Pinkas H.
        • Shochat T.
        • Fisch B.
        Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level.
        Fertil. Steril. 2015; 103: 669-674
        • Singh N.
        • Malik N.
        • Malhotra N.
        • Vanamail P.
        • Gupta M.
        Impact of progesterone (on hCG day)/oocyte ratio on pregnancy outcome in long agonist non donor fresh IVF/ICSI cycles.
        Taiwan. J. Obstet. Gynecol. 2016 Aug; 55: 503-506
        • Sunkara S.K.
        • Rittenberg V.
        • Raine-Fenning N.
        • Bhattacharya S.
        • Zamora J.
        • Coomarasamy A.
        Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.
        Hum. Reprod. 2011 Jul; 26: 1768-1774
        • Tang Y.
        • Gong F.
        • Lin G.
        • Lu G.
        Early follicular progesterone concentrations and in vitro fertilization pregnancy outcomes.
        Fertil. Steril. 2007 Apr; 87: 991-994
        • Templeton A.
        • Morris J.K.
        • Parslow W.
        Factors that affect outcome of in-vitro fertilisation treatment.
        Lancet. 1996; 348: 1402-1406
        • Van Vaerenbergh I.
        • Fatemi H.M.
        • Blockeel C.
        • Van Lommel L.
        • In't Veld P.
        • Schuit F.
        • Kolibianakis E.M.
        • Devroey P.
        • Bourgain C.
        Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression.
        Reprod. Biomed. Online. 2011; 22: 263-271
        • Venetis C.A.
        • Kolibianakis E.M.
        • Bosdou J.K.
        • Tarlatzis B.C.
        Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles.
        Hum. Reprod. Update. 2013; 19: 433-457
        • Venetis C.A.
        • Kolibianakis E.M.
        • Bosdou J.K.
        • Lainas G.T.
        • Sfontouris I.A.
        • Tarlatzis B.C.
        • Lainas T.G.
        Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
        Hum. Reprod. 2016 Aug; 31: 1859-1865
        • Xu B.
        • Li Z.
        • Zhang H.
        • Jin L.
        • Li Y.
        • Ai J.
        • Zhu G.
        Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
        Fertil. Steril. 2012; 97: 1321-1327
        • Yang S.
        • Pang T.
        • Li R.
        • Yang R.
        • Zhen X.
        • Chen X.
        • Wang H.
        • Ma C.
        • Liu P.
        • Qiao J.
        The individualized choice of embryo transfer timing for patients with elevated serum progesterone level on the HCG day in IVF/ICSI cycles: a prospective randomized clinical study.
        Gynecol. Endocrinol. 2015; 31: 355-358
        • Yding Andersen C.
        • Bungum L.
        • Nyboe Andersen A.
        • Humaidan P.
        Preovulatory progesterone concentration associates significantly to follicle number and LH concentration but not to pregnancy rate.
        Reprod. Biomed. Online. 2011; 23: 187-195
        • Younis J.S.
        • Matilsky M.
        • Radin O.
        • Ben-Ami M.
        Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
        Fertil. Steril. 2001; 76: 294-299

      Biography

      Dr Philippe ARVIS obtained his medical training (MBBS) in 1974 and MD in Obstetrics and Gynaecology in 1984. He further specialized in Reproductive Medicine at the University Hospital, Rennes, France, and has been working as an infertility and reproductive medicine consultant in the ART unit of Clinique La Sagesse, Rennes, France.
      Key message
      Progesterone concentration at HCG administration (PHCG) negatively affects live birth rate at lower and higher values. In poor responders, the effect of PHCG elevation is minimal so cancellations or embryo freezing are unnecessary. In higher responders, the negative effect is more pronounced, and freeze-all policy should be widely applied.